Pharmacotherapy Home




Burgess, David S., Pharm.D.
Division Head and
Fellow to the James T. Doluisio Chair
in Pharmacy
Clinical Professor of Pharmacotherapy
210- 567-8329

Research Interests

My research interests lie in the area of infectious disease clinical, laboratory, and translational research due to bacteria and fungus. My group is focused on understanding the mechanisms of resistance, pharmacokinetics, pharmacodynamics, and outcomes of antibacterial and antifungal pharmacotherapy. This is being accomplished by evaluating

  • in vitro activity of antifungal and antimicrobial agents alone and in combination for the treatment of serious fungal infections, gram-positive pathogens and gram-negative pathogens   such as P. aeruginosa , Acinetobacter , and extended-spectrum beta-lactamase producing Klebsiella,
  • pharmacokinetics and pharmacodynamics of antifungal and antimicrobials in vitro and in vivo,
  • epidemiology of anti-infective resistance, anti-infective usage patterns and the relationships between resistance, anti-infective usage, and pharmacodynamics.
  • outcomes of disease state management programs which we developed and implemented for infectious diseases.

Finally, we enjoy providing education and training to healthcare professionals and the general public about the appropriate and rational use of anti-infectives.

More information about Dr. Burgess
> Biographical Sketch
> Teaching Responsibilities
> Publications
> Abstracts
Last Reviewed: January 19, 2010

Division Information

Mailing Address:
Education & Research Ctr.
College of Pharmacy
The University of Texas
Health Science Center
7703 Floyd Curl Drive - MC 6220
San Antonio, TX

Email Address: pharmacy


Reveles Traces Rate of Hospital Infections

Dr. Kelly Reveles, assistant professor of pharmacotherapy, is primary author of a study which found that the incidence of Clostridium difficile infection (CDI), a highly contagious gastrointestinal disease often linked to the overprescribing of antibiotics, nearly doubled between 2001 and 2010. It also determined there were no improvements in patient health outcomes, including mortality or hospital length of stay, over the study period.

Read more about Reveles' study.

index of the major headings: a b c d e f g h i j k l m n o p q r s t u v w x y z